Skip to main content
Hit enter to search or ESC to close
Close Search
AngioGenexAngioGenexAngioGenexAngioGenexAngioGenex
Menu
  • About
    • Company Overview
    • Leadership
    • Collaborations
    • Presentations
  • Platform
    • Platform Overview
    • Publications
    • Intellectual Property
  • Pipeline
    • Pipeline Overview
    • AGX-A
    • Cholangiocarcinoma
    • Age-related macular degeneration (AMD)
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
    • General Inquiries
    • Partnership Inquiries
    • Career Opportunities
Investors

Press Releases

Overview
Press Releases     
Company Information
Stock Information
SEC Filings
Corporate Governance

Recent Press Releases

Angiogenex Co-Developing Anti-Cancer Drug With World Renowned Cancer Center
February 13, 2020
Michael Aronstein to Head AngioGenex Board of Directors
December 5, 2017
AngioGenex Newsroom

Recent Media Coverage

What Is Angiogenesis? (via Sloan Kettering Institute)
March 13, 2014
DNA pioneer James Watson takes aim at “cancer establishments” (via Reuters)
January 9, 2013

About

Platform

Pipeline

Newsroom

Investors

Contact

Subscribe to Receive News Alerts

© 2022 AngioGenex | Terms of Use | Privacy Policy
Close Menu
  • About
    • Company Overview
    • Leadership
    • Collaborations
    • Presentations
  • Platform
    • Platform Overview
    • Publications
    • Intellectual Property
  • Pipeline
    • Pipeline Overview
    • AGX-A
    • Cholangiocarcinoma
    • Age-related macular degeneration (AMD)
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
    • General Inquiries
    • Partnership Inquiries
    • Career Opportunities